LOS ANGELES CAPITAL MANAGEMENT LLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$107,000
-94.0%
14,545
-85.0%
0.00%
-95.5%
Q3 2013$1,780,000
+23.4%
96,755
+17.2%
0.02%
+10.0%
Q2 2013$1,443,00082,5250.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,331,100$23,281,0008.28%
DAFNA Capital Management LLC 191,215$3,344,0004.89%
Redmile Group, LLC 1,277,109$22,337,0003.94%
BB BIOTECH AG 3,115,371$54,488,0003.92%
SECTORAL ASSET MANAGEMENT INC 5,292,682$92,569,0002.74%
IRONWOOD INVESTMENT MANAGEMENT LLC 565,956$9,899,0001.76%
OAK RIDGE INVESTMENTS LLC 2,645,781$46,275,0001.45%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,104$22,127,0001.04%
Tekla Capital Management LLC 412,965$7,223,0000.98%
Private Capital Advisors, Inc. 127,600$2,232,0000.83%
View complete list of ARIAD PHARMACEUTICALS INC shareholders